BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

400 related articles for article (PubMed ID: 15961551)

  • 1. Quantification of lipoprotein subclasses by proton nuclear magnetic resonance-based partial least-squares regression models.
    Petersen M; Dyrby M; Toubro S; Engelsen SB; Nørgaard L; Pedersen HT; Dyerberg J
    Clin Chem; 2005 Aug; 51(8):1457-61. PubMed ID: 15961551
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of insulin resistance and type 2 diabetes on lipoprotein subclass particle size and concentration determined by nuclear magnetic resonance.
    Garvey WT; Kwon S; Zheng D; Shaughnessy S; Wallace P; Hutto A; Pugh K; Jenkins AJ; Klein RL; Liao Y
    Diabetes; 2003 Feb; 52(2):453-62. PubMed ID: 12540621
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum cholesterol and triglyceride reference ranges of twenty lipoprotein subclasses for healthy Japanese men and women.
    Furusyo N; Ai M; Okazaki M; Ikezaki H; Ihara T; Hayashi T; Hiramine S; Ura K; Kohzuma T; Schaefer EJ; Hayashi J
    Atherosclerosis; 2013 Dec; 231(2):238-45. PubMed ID: 24267234
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proton magnetic resonance spectroscopy of fractionated plasma lipoproteins and reconstituted plasma from healthy subjects and patients with cancer.
    Engan T; Bjerve KS; Høe AL; Krane J
    Scand J Clin Lab Invest; 1992 Sep; 52(5):393-408. PubMed ID: 1514018
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relation of lipoprotein subclasses as measured by proton nuclear magnetic resonance spectroscopy to coronary artery disease.
    Freedman DS; Otvos JD; Jeyarajah EJ; Barboriak JJ; Anderson AJ; Walker JA
    Arterioscler Thromb Vasc Biol; 1998 Jul; 18(7):1046-53. PubMed ID: 9672064
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dose-dependent action of atorvastatin in type IIB hyperlipidemia: preferential and progressive reduction of atherogenic apoB-containing lipoprotein subclasses (VLDL-2, IDL, small dense LDL) and stimulation of cellular cholesterol efflux.
    Guerin M; Egger P; Soudant C; Le Goff W; van Tol A; Dupuis R; Chapman MJ
    Atherosclerosis; 2002 Aug; 163(2):287-96. PubMed ID: 12052475
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A systematic approach to obtain validated partial least square models for predicting lipoprotein subclasses from serum NMR spectra.
    Mihaleva VV; van Schalkwijk DB; de Graaf AA; van Duynhoven J; van Dorsten FA; Vervoort J; Smilde A; Westerhuis JA; Jacobs DM
    Anal Chem; 2014 Jan; 86(1):543-50. PubMed ID: 24319989
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lipoprotein remnants and dense LDL are associated with features of unstable carotid plaque: a flag for non-HDL-C.
    Zambon A; Puato M; Faggin E; Grego F; Rattazzi M; Pauletto P
    Atherosclerosis; 2013 Sep; 230(1):106-9. PubMed ID: 23958261
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lipoprotein subclass measurements by nuclear magnetic resonance spectroscopy improve the prediction of coronary artery disease in Type 1 diabetes. A prospective report from the Pittsburgh Epidemiology of Diabetes Complications Study.
    Soedamah-Muthu SS; Chang YF; Otvos J; Evans RW; Orchard TJ;
    Diabetologia; 2003 May; 46(5):674-82. PubMed ID: 12743701
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantification of plasma lipoprotein fractions by wavelet transform time-domain data processing of the proton nuclear magnetic resonance methylene spectral region.
    Serrai H; Nadal L; Leray G; Leroy B; Delplanque B; de Certaines JD
    NMR Biomed; 1998 Oct; 11(6):273-80. PubMed ID: 9802469
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of mild to moderately elevated triglycerides on low density lipoprotein subfraction concentration and composition in healthy men with low high density lipoprotein cholesterol levels.
    Halle M; Berg A; Baumstark MW; König D; Huonker M; Keul Joseph
    Atherosclerosis; 1999 Mar; 143(1):185-92. PubMed ID: 10208494
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sex and age differences in lipoprotein subclasses measured by nuclear magnetic resonance spectroscopy: the Framingham Study.
    Freedman DS; Otvos JD; Jeyarajah EJ; Shalaurova I; Cupples LA; Parise H; D'Agostino RB; Wilson PW; Schaefer EJ
    Clin Chem; 2004 Jul; 50(7):1189-200. PubMed ID: 15107310
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The inherent accuracy of 1H NMR spectroscopy to quantify plasma lipoproteins is subclass dependent.
    Ala-Korpela M; Lankinen N; Salminen A; Suna T; Soininen P; Laatikainen R; Ingman P; Jauhiainen M; Taskinen MR; Héberger K; Kaski K
    Atherosclerosis; 2007 Feb; 190(2):352-8. PubMed ID: 16730730
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship between plasma lipid concentrations and HDL subclasses.
    Yang Y; Yan B; Fu M; Xu Y; Tian Y
    Clin Chim Acta; 2005 Apr; 354(1-2):49-58. PubMed ID: 15748599
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Distribution of lipoproteins triglyceride and lipoprotein cholesterol in an adult population by age, sex, and hormone use- The Pacific Northwest Bell Telephone Company health survey.
    Wahl PW; Warnick GR; Albers JJ; Hoover JJ; Walden CE; Bergelin RO; Ogilvie JT; Hazzard WR; Knopp RH
    Atherosclerosis; 1981 Apr; 39(1):111-24. PubMed ID: 6941788
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of bezafibrate on lipoprotein subclasses and inflammatory markers in patients with hypertriglyceridemia--a nuclear magnetic resonance study.
    Ikewaki K; Noma K; Tohyama J; Kido T; Mochizuki S
    Int J Cardiol; 2005 Jun; 101(3):441-7. PubMed ID: 15907413
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hyperapobetalipoproteinemia with compositional abnormality of LDL and IDL, a characteristic lipoprotein alteration in essential hypertension.
    Ryomoto KI; Suzuki M; Kanazawa A; Hasegawa M; Kimura Y; Yamamura T; Harano Y
    Am J Hypertens; 2000 Jun; 13(6 Pt 1):617-24. PubMed ID: 10912744
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma lipoprotein changes during abstinence in chronic alcoholics.
    Weidman SW; Beard JD; Sabesin SM
    Atherosclerosis; 1984 Aug; 52(2):151-66. PubMed ID: 6433939
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increases in dietary cholesterol and fat raise levels of apoprotein E-containing lipoproteins in the plasma of man.
    Cole TG; Patsch W; Kuisk I; Gonen B; Schonfeld G
    J Clin Endocrinol Metab; 1983 Jun; 56(6):1108-15. PubMed ID: 6841553
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantification of plasma lipids and apolipoproteins by use of proton NMR spectroscopy, multivariate and neural network analysis.
    Bathen TF; Krane J; Engan T; Bjerve KS; Axelson D
    NMR Biomed; 2000 Aug; 13(5):271-88. PubMed ID: 10960918
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.